Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study
Article in RMD Open (May 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in RMD Open (May 2024)
Article in Rheumatology and Therapy (April 2024)
Article in Expert Review of Clinical Pharmacology (April 2024)